ADxLR5® Reader System

ADxLR5® Reader System is a CE marked and FDA registered lateral flow assay reader used for producing quantitative results from lateral flow assays.

Abingdon Health customers use the ADxLR5® Reader System alongside lateral flow technology products, Seralite®– FLC Serum and Seralite®– FLC Urine. Both assays are designed for the quantitative measurement of kappa and lambda immunoglobulin free light chains (FLC) to aid in the diagnosis and monitoring of multiple myeloma patients.

By combining reader and lateral flow technology,Seralite®– FLC Serum andSeralite®– FLC Urineenables the provision of FLC results in ~10 minutes rather than days or weeks via other diagnostic methods. With this simple to use, compact, rapid test, clinicians are able to monitor patients in “real time” supporting faster decision making.

Advantages of ADxLR5® Reader System

With an ever demanding diagnostic marketplace, ADxLR5® Reader System has been designed with the end user in mind. The reader is easy to use and contains a simple step-by-step operating process that requires little training. Below gives an insight into why ADxLR5® Reader System should be considered for lateral flow assays that require quantification.

Features

Benefits

Flexible, soft close sample draw

Can be used to read a wide range of devices

Sample data imported via barcode scanner

Rapid and accurate results

Data can be transferred via Wi-Fi, USB or securely using the Ethernet connection

Customisation

The ADxLR5® Reader System technology can also be customised to read single or multiplexed lateral flow assays, as well as multiple assays and as such is also an OEM option for customers. In addition, its compliance with regulatory requirements means it is acceptable for use in many different industry sectors. A list of customisation options can be found on our Lateral Flow Reader OEM page.

For more information about the ADxLR5® Reader System please contact us on +44 (0) 1904 406080 or info@abingdonhealth.com.